These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15087700)

  • 1. Resolution of hereditary hemorrhagic telangiectasia and anemia with prolonged alpha-interferon therapy for chronic hepatitis C.
    Massoud OI; Youssef WI; Mullen KD
    J Clin Gastroenterol; 2004 Apr; 38(4):377-9. PubMed ID: 15087700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary hemorrhagic telangiectasia showing severe anemia which was successfully treated with estrogen.
    Hisada T; Kuwabara H; Tsunoda T; Kaneko K; Kubota S; Miwa Y; Mori M
    Intern Med; 1995 Jun; 34(6):589-92. PubMed ID: 7549150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options.
    Flanagan BA; Collins C; Parra S
    Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon for metastatic renal cell cancer causing regression of hereditary hemorrhagic telangiectasia.
    Wheatley-Price P; Shovlin C; Chao D
    J Clin Gastroenterol; 2005 Apr; 39(4):344-5. PubMed ID: 15758631
    [No Abstract]   [Full Text] [Related]  

  • 5. Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.
    Huemer F; Dejaco M; Grabmer C; Melchardt T; Neureiter D; Mayer G; Egle A; Greil R; Weiss L
    Wien Klin Wochenschr; 2017 Feb; 129(3-4):141-144. PubMed ID: 27878613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab as a treatment for hereditary hemorrhagic telangiectasia in children: a case report.
    Ospina FE; Echeverri A; Posso-Osorio I; Jaimes L; Gutierrez J; Tobón GJ
    Colomb Med (Cali); 2017 Jun; 48(2):88-93. PubMed ID: 29021642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential antiviral and iron chelation treatment in a teenage boy with congenital anemia, chronic hepatitis C, and secondary hemosiderosis.
    Yap J; O'Connor C; Kirby M; Guindi M; Roberts EA
    J Pediatr Gastroenterol Nutr; 2009 Mar; 48(3):382-5. PubMed ID: 19274798
    [No Abstract]   [Full Text] [Related]  

  • 8. Hereditary hemorrhagic telangiectasia: a rare cause of severe anemia.
    dos Santos JW; Dalcin TC; Neves KR; Mann KC; Pretto GL; Bertolazi AN
    J Bras Pneumol; 2007; 33(1):109-12. PubMed ID: 17568877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary hemorrhagic telangiectasia response to aminocaproic acid treatment.
    Annichino-Bizzacchi JM; Facchini RM; Torresan MZ; Arruda VR
    Thromb Res; 1999 Oct; 96(1):73-6. PubMed ID: 10554087
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study.
    Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J
    Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of interferon alpha treatment in chronic hepatitis C.
    Berg T; Kaul T; Heuft HG; Naumann U; Lobeck H; Wiedenmann B; Hopf U
    J Hepatol; 1998 Sep; 29(3):511-2. PubMed ID: 9765005
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon alfa-induced pernicious anemia in chronic hepatitis C infection.
    Willson RA
    J Clin Gastroenterol; 2001; 33(5):426-7. PubMed ID: 11606867
    [No Abstract]   [Full Text] [Related]  

  • 13. Gastrointestinal lesions in hereditary hemorrhagic telangiectasia.
    Vase P; Grove O
    Gastroenterology; 1986 Nov; 91(5):1079-83. PubMed ID: 3489651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact endoscopic findings in hereditary hemorrhagic telangiectasia.
    Geisthoff UW; Sittel C; Plinkert PK
    Head Neck; 2006 Jan; 28(1):56-63. PubMed ID: 16302189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pernicious anemia associated with interferon-alpha therapy and chronic hepatitis C infection.
    Andrès E; Loukili NH; Ben Abdelghani M; Noel E
    J Clin Gastroenterol; 2004 Apr; 38(4):382. PubMed ID: 15087703
    [No Abstract]   [Full Text] [Related]  

  • 16. [Familial study of patients with hereditary hemorrhagic telangiectasia].
    Noval Menéndez J; Nuño Mateo F; Anitúa Roldán MJ; López Muñiz A; Fuente Martín E; Gallo Alvaro C
    An Med Interna; 1998 Oct; 15(10):534-7. PubMed ID: 9844229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hereditary hemorrhagic telangiectasia].
    Plauchu H; Dupuis-Girod S
    Rev Prat; 2009 Sep; 59(7):899-903. PubMed ID: 19839452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemangioma of the uterus associated with hereditary hemorrhagic telangiectasia.
    Shanberge JN
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):708-10. PubMed ID: 9205458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eradication of hepatitis C virus after 3 months of interferon treatment in a patient with chronic hepatitis C].
    Winkfield B; Lunel F; Beurrier P; Calès P
    Gastroenterol Clin Biol; 2000 Jan; 24(1):136-7. PubMed ID: 10755865
    [No Abstract]   [Full Text] [Related]  

  • 20. Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C.
    Kasahara A; Hiraide A; Tomita N; Iwahashi H; Imagawa A; Ohguro N; Yamamoto S; Mita E; Hayashi N
    J Gastroenterol; 2004 Nov; 39(11):1106-9. PubMed ID: 15580406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.